Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 28 Dec 2016 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2019.
- 28 Dec 2016 Status changed from not yet recruiting to recruiting.
- 18 Aug 2016 New trial record